Neutral impactCorporate Action
Natco Pharma Limited — Committee Meeting Updates
NSE 1 hr ago·23 Oct 2026, 3:35 pm
Natco PharmaNatco Pharma Limited has informed the Exchange regarding the approval of allotment of 17058082 Equity shares pursuant to Rights Issue by the Fund-Raising Committee at its meeting held on October 23, 2026
Affected stocks
Neutral1 stockBull / bear label is derived from the article's AI sentiment — indicative, not advice. Prices may be delayed.
Key takeaways
- Concerns Natco Pharma (NATCOPHARM).
- Category: Corporate Action.
Why it matters
A routine update for Natco Pharma. Use the price and stock snapshot to gauge how the market is responding.
